{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-271006","form_type":"8-K","ticker":"FLGT","cik":"0001674930","company_name":"Fulgent Genetics, Inc.","filed_at":"2025-11-07T23:59:59+00:00","discovered_at":"2026-05-14T18:02:40.117500+00:00","generated_at":"2026-05-16T23:05:25.462994+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Fulgent Genetics Q3 revenue $84.1M (+17% YoY), raises FY guidance, non-GAAP EPS $0.14","bullets":["Revenue $84.1M, up 17% YoY; raised full-year 2025 revenue guidance to $325.0M.","GAAP net loss $6.6M ($0.21/share); non-GAAP net income $4.5M ($0.14/share).","Full-year EPS guidance raised: GAAP loss ~($1.70)/share, non-GAAP income $0.30/share.","Adjusted EBITDA $0.7M; GAAP gross margin 42.2%, non-GAAP 44.3%.","Cash and short-term investments $787.7M at quarter end."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-271006","json":"https://secwatch.observer/filing/0001193125-25-271006.json","markdown":"https://secwatch.observer/filing/0001193125-25-271006.md","text":"https://secwatch.observer/filing/0001193125-25-271006.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1674930/000119312525271006/0001193125-25-271006-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1674930/000119312525271006/flgt-20251107.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T23:05:25.462994+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}